Previous 10 | Next 10 |
NEW YORK, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has signed a licensing agreement with Restorsea , a leading medical grade skincare technology platform. Conversion Labs plans...
Dizzying triple-digit rate growth looks to be continuing for quite a while due to the introduction of a new platform. The company can add brands and products almost at will. The platform and marketing capabilities can be leveraged endlessly. Its core competence is online marketing...
Conversion Labs (CVLB) appointed healthcare veteran, Dr. Connie Mariano, to its board; she is an U.S. Navy Rear Admiral and the first military woman to be appointed White House Physician.She will advise company management on health care services and product development related ...
NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed healthcare veteran, Dr. Connie Mariano , to its board of directors. Following her appointment, the board will have eight members...
For Q3, Conversion Labs ([[CVLB]] +3.5%) expects revenue of ~$11.2M, up 23% Q/Q and up 254% Y/Y driven by another strong month in September, with revenues totaling ~$3.9M, up 258% Y/Y.It expects to report Annual recurring revenue ((ARR)) from subscriptions to products and servi...
NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited results for its third quarter ended September 30, 2020. Revenues for the third quarter are expected to total approx...
Conversion Labs ( OTCQB:CVLB ) announced equity investment by a select group of private investors and family offices, including investors David Blitzer and Wes Edens, for $3.5M. More news on: Conversion Labs, Inc., Healthcare stocks news, Read more ...
NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has completed its previously announced equity investment by a select group of private investors and family offices, including investors David Bl...
NEW YORK, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has reported record revenues of $3.7 million for the month of August, up more than 267% versus August 2019. August results indicate an ov...
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-patient telehealth company, has been invited to present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held on February 17...
NEW YORK, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-patient telehealth company, will change its name to Life MD™ on February 22, followed by the official launch of its subscription-based primary care and concierge ser...
NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has appointed Marc Benathen as chief financial officer, effective March 1. He succeeds Juan Manuel Piñeiro Dagnery, who will continu...